Silver Book Fact

Medicare beneficiaries with vision loss incur significantly higher costs than individuals with normal vision. Approximately 90% of the higher annual costs are non-eye related medical costs– $2,193 for those with moderate loss, $3,301 for those with severe loss, and $4,443 for those who are blind. Extrapolating to the entire Medicare population, blindness and vision loss are associated with $2.14 billion in non-eye related costs (in 2003 dollars).

Javitt J, Zhou Z, Wilke R. Association Between Vision Loss and Higher Medical Care Costs in Medicare Beneficiaries: Costs are greater for those with progressive vision loss. Ophthalmology. 2007; 114(2): 238-45. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17270673&dopt=AbstractPlus

Reference

Title
Association Between Vision Loss and Higher Medical Care Costs in Medicare Beneficiaries: Costs are greater for those with progressive vision loss
Publication
Ophthalmology
Publication Date
2007
Authors
Javitt J, Zhou Z, Wilke R
Volume & Issue
Volume 114, Issue 2
Pages
238-45
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • The excess economic burden of visual impairment and blindess of individuals age 40 and older on the individual, caregivers, and other health care payers is an estimated $5.48 billion annually–…  
  • The annual direct medical costs (including outpatient, inpatient, and prescription drug services) for Americans age 40 and older with glaucoma is $2.86 billion.  
  • Every year, 200,000 Americans develop advanced age-related macular degeneration (AMD).  
  • Around $62 million a year is spent on guide dogs for individuals 40 years and older with visual impairment (in 2004 dollars).  
  • Visual loss from subfoveal choroidal neovascularization, a characteristic of wet age-related macular degeneration (AMD), was found to have a profound impact on how patients felt about their health-related quality of…